CD8A and myeloid sarcoma: We have hypothesized that a genetically determined defect in the elimination of EBV-infected B cells by cytotoxic CD8+ T cells might predispose to the development of MS by allowing EBV-infected autoreactive B cells to accumulate in the central nervous system [3,6].